Related Experiment Video
Updated: Jul 28, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Germinal Matrix-Intraventricular Hemorrhage: A Tale of Preterm Infants
Walufu Ivan Egesa1, Simon Odoch1, Richard Justin Odong1
1Department of Paediatrics and Child Health, Faculty of Clinical Medicine and Dentistry, Kampala International University, Uganda.
Insights
Germinal matrix-intraventricular hemorrhage (GM-IVH) is a frequent brain complication in preterm infants, leading to severe neurodevelopmental issues. This review details GM-IVH
Area of Science:
- Neonatal Neurology
- Pediatric Neurosurgery
- Developmental Neuroscience
Background:
- Germinal matrix-intraventricular hemorrhage (GM-IVH) is a significant intracranial complication in preterm infants, particularly those born before 32 weeks gestation.
- Hemorrhage originates in the germinal matrix's fragile capillaries, potentially progressing into the ventricles.
- GM-IVH is linked to increased mortality and adverse neurodevelopmental outcomes, including hydrocephalus, cerebral palsy, and cognitive impairments.
Purpose of the Study:
- To provide a comprehensive review of germinal matrix-intraventricular hemorrhage (GM-IVH) in preterm neonates.
- To synthesize current knowledge on GM-IVH pathogenesis, grading, incidence, risk factors, and diagnosis.
- To explore management, prevention strategies, and outcomes associated with GM-IVH and posthemorrhagic hydrocephalus.
Main Methods:
- Literature review and synthesis.
- Synopsis of existing research on GM-IVH.
- Exploration of management and prevention strategies.
Main Results:
- GM-IVH is a common complication in vulnerable preterm infants.
- Diagnosis is typically achieved via transfontanellar ultrasound, as neonates are often asymptomatic.
- The review covers pathogenesis, risk factors, diagnosis, outcomes, and interventions for GM-IVH.
Conclusions:
- GM-IVH poses a substantial risk for preterm infants, impacting mortality and long-term neurodevelopment.
- Early diagnosis and understanding of risk factors are crucial for management.
- Further research into effective prevention and management strategies is warranted to improve outcomes.
Abstract:
Germinal matrix-intraventricular hemorrhage (GM-IVH) is a common intracranial complication in preterm infants, especially those born before 32 weeks of gestation and very-low-birth-weight infants. Hemorrhage originates in the fragile capillary network of the subependymal germinal matrix of the developing brain and may disrupt the ependymal lining and progress into the lateral cerebral ventricle. GM-IVH is associated with increased mortality and abnormal neurodevelopmental outcomes such as posthemorrhagic hydrocephalus, cerebral palsy, epilepsy, severe cognitive impairment, and visual and hearing impairment. Most affected neonates are asymptomatic, and thus, diagnosis is usually made using real-time transfontanellar ultrasound. The present review provides a synopsis of the pathogenesis, grading, incidence, risk factors, and diagnosis of GM-IVH in preterm neonates. We explore brief literature related to outcomes, management interventions, and pharmacological and nonpharmacological prevention strategies for GM-IVH and posthemorrhagic hydrocephalus.
